Ownership history in VANGUARD GROUP INC · 11 quarters on record
This page tracks every 13F SEC filing in which VANGUARD GROUP INC reported a position in ACURX PHARMACEUTICALS INC (ACXP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 23,280 | -122,257 | -84.0% | 0.00% | $58K | $2.49 |
| 2025 Q2 | REDUCED | 145,537 | -383,812 | -72.5% | 0.00% | $74K | $10.22 |
| 2025 Q1 | UNCHANGED | 529,349 | — | 0% | 0.00% | $206K | $7.80 |
| 2024 Q4 | UNCHANGED | 529,349 | — | 0% | 0.00% | $431K | $16.28 |
| 2024 Q3 | ADDED | 529,349 | +37,662 | +7.7% | 0.00% | $1.0M | $38.00 |
| 2024 Q2 | UNCHANGED | 491,687 | — | 0% | 0.00% | $1.1M | $45.00 |
| 2024 Q1 | ADDED | 491,687 | +85,300 | +21.0% | 0.00% | $1.2M | $49.00 |
| 2023 Q4 | ADDED | 406,387 | +285,143 | +235.2% | 0.00% | $1.6M | $76.60 |
| 2023 Q3 | ADDED | 121,244 | +200 | +0.2% | 0.00% | $182K | $30.00 |
| 2023 Q2 | ADDED | 121,044 | +31,559 | +35.3% | 0.00% | $321K | $53.00 |
As of 2025 Q4 — sorted by position size